Admission Date:  [**2133-1-27**]              Discharge Date:   [**2133-2-6**]  Date of Birth:  [**2071-5-26**]             Sex:   M  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 1493**] Chief Complaint: Post-procedure monitoring  Major Surgical or Invasive Procedure: Percutaneous liver biopsy Embolization for ruptured and bleeding HCC  History of Present Illness: Mr. [**Known lastname 35507**] is a 61 y/oM with HIV and HCV and Hemophilia A with suspicion for diffuse neoplastic process of the liver found on routine ultrasound earlier this month admitted for biopsy and post-bx observation for bleeding.
He was treated [**2127**]-[**2128**] with interferon, and acheived virologic response but subsequently relapsed.
He requires a special regimen for replacing factor aroudn this time.
Past Medical History: Hemophilia A - followed by Dr [**Last Name (STitle) 13933**], Drs [**Last Name (STitle) 2805**] and [**Name5 (PTitle) **] - arthropathy in elbows, ankles, neck, on Ms Contin - s/p multiple b/l knee replacements .
HCV genotype II and IV - followed by Dr [**Last Name (STitle) **]; relapsed [**9-3**] s/p peg interferon and ribavirin for 48 weeks ([**Date range (1) 101752**]).
Founded an international nonprofit organization.
somewhat distended EXT: no edema   Pertinent Results: LABORATORY STUDIES  COMPLETE BLOOD COUNT [**2133-1-27**] 09:00AM BLOOD WBC-5.8 RBC-4.81 Hgb-14.9 Hct-44.1 MCV-92 MCH-31.0 MCHC-33.7 RDW-14.3 Plt Ct-76* [**2133-1-28**] 05:30AM BLOOD WBC-6.1 RBC-4.57* Hgb-14.5 Hct-42.5 MCV-93 MCH-31.7 MCHC-34.1 RDW-14.3 Plt Ct-81* [**2133-1-31**] 03:40AM BLOOD WBC-23.1* RBC-3.80* Hgb-11.8* Hct-35.2* MCV-93 MCH-31.2 MCHC-33.7 RDW-15.4 Plt Ct-199 [**2133-2-5**] 05:05AM BLOOD WBC-12.4* RBC-3.77* Hgb-11.7* Hct-35.7* MCV-95 MCH-31.0 MCHC-32.7 RDW-17.3* Plt Ct-128* [**2133-2-6**] 05:50AM BLOOD WBC-11.2* RBC-3.62* Hgb-11.2* Hct-34.2* MCV-95 MCH-30.9 MCHC-32.7 RDW-16.6* Plt Ct-107*  COAGULATION [**2133-1-27**] 09:00AM BLOOD PT-15.6* INR(PT)-1.4* [**2133-2-6**] 05:50AM BLOOD PT-16.8* PTT-48.8* INR(PT)-1.5*  FACTOR VIII LEVELS [**2133-1-27**] 11:10AM BLOOD FacVIII-43* [**2133-1-27**] 04:57PM BLOOD FacVIII-39* [**2133-1-28**] 04:55PM BLOOD FacVIII-61 [**2133-1-29**] 05:30AM BLOOD FacVIII-68 [**2133-1-29**] 01:00PM BLOOD FacVIII-79 [**2133-1-29**] 05:15PM BLOOD FacVIII-76 [**2133-1-30**] 12:07AM BLOOD FacVIII-77 [**2133-1-30**] 05:24PM BLOOD FacVIII-82 [**2133-1-31**] 06:25PM BLOOD FacVIII-57 [**2133-2-1**] 05:37PM BLOOD FacVIII-74  CHEMISTRY [**2133-1-28**] 05:30AM BLOOD Glucose-119* UreaN-14 Creat-0.7 Na-130* K-4.0 Cl-100 HCO3-26 AnGap-8 [**2133-2-6**] 05:50AM BLOOD Glucose-97 UreaN-22* Creat-0.7 Na-134 K-3.4 Cl-98 HCO3-29 AnGap-10 [**2133-1-28**] 05:30AM BLOOD ALT-39 AST-54* AlkPhos-131* TotBili-3.5* [**2133-2-1**] 04:52AM BLOOD ALT-129* AST-131* LD(LDH)-244 AlkPhos-150* Amylase-21 TotBili-7.4* DirBili-4.5* IndBili-2.9 [**2133-2-6**] 05:50AM BLOOD ALT-35 AST-39 AlkPhos-135* TotBili-8.9* [**2133-1-28**] 05:30AM BLOOD Albumin-2.2* Calcium-7.7* Phos-2.1* Mg-1.7 [**2133-2-6**] 05:50AM BLOOD Calcium-7.8* Phos-2.6* Mg-2.1  REPORTS AND STUDIES:  LIVER BIOPSY Liver, needle core biopsy: Foci of hepatocellular carcinoma, well-moderately differentiated.. Immunostains of the tumor  are positive for HepPar 1, unabsorbed CEA, and CAM 5.2; and negative for cytokeratins AE1:AE3, CK7 and CK20, with satisfactory controls.
He received peri-procedural recombinant factor VIII.
LIVER BIOPSY: Mr. [**Known lastname 35507**] was admitted for elective liver biospy and observation given his hemophilia.
HEMOPHILIA: The patient received intravenous recombinant Factor VIII peri-procedurally.
He was received additional factor at the time of HCC rupture.
He underwent emergent embolization in the angiography suite.
He did not require transfusions and his hematocrit nadir was 31.
He was given factorVIII per heme/onc recomendations.
He was placed on CPAP with improvement in his oxygenation.
He was placed on lasix and spironolactone with improvement.
He was continued on these diuretics at discharge.
CHRONIC PAIN CONTROL: The patient received his MS Contin and PO dilaudid as per his home regimen.
Medications on Admission: acyclovir 800mg po BID prn herpes flare androgel 1.25gram transderm po Qday Cialis 10mg po Qprn Dialusis 4mg po [**12-31**] QHS prn floxin (ear drops) 0.3% OT left ear QID Kaletra 200mg-50 2 tablets po BID MS contin 30mg po 1-2 tabs q6hours prn Nadolol 20mg po Qday Refacto prn (factor VII) Selenium (dosage unknown) Viread 300mg po Qday Ziagen 300mg po qday Vitamin C oral   Discharge Medications: 1.
Abacavir 300 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Tenofovir Disoproxil Fumarate 300 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Lopinavir-Ritonavir 200-50 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day).
Nadolol 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Hexavitamin     Tablet Sig: One (1) Cap PO DAILY (Daily).
Morphine 15 mg Tablet Sustained Release Sig: Three (3) Tablet Sustained Release PO QAM ON AWAKENING ().
Morphine 30 mg Tablet Sustained Release Sig: One (1) Tablet Sustained Release PO Q4H (every 4 hours) as needed for PRN Pain.
Hydromorphone 4 mg Tablet Sig: One (1) Tablet PO Q2H (every 2 hours) as needed for pain.
Celebrex 100 mg Capsule Sig: One (1) Capsule PO twice a day as needed for pain.
AndroGel 1.25 g/Actuation Gel in Metered-dose Pump Sig: One (1) application Transdermal once a day: prescribed by [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 6164**].
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Furosemide 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Spironolactone 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO TID (3 times a day) as needed for encephalopathy.
Discharge Instructions: You were admitted for monitoring after your liver biopsy.
You had a spontaneous bleed from another section of your liver that required embolization and monitoring in the intensive care unit.
Your hematocrit has remained stable.
It is felt that your shoulder pain is likely due to referred pain from the site of your liver biopsy and diaphragmatic irritation.
You were started on LASIX and SPIRONOLACTONE to remove fluid in your abdomen.
Followup Instructions: You have an appointment with Gastrointestinal Oncology: Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 8950**], MD [**First Name8 (NamePattern2) **] [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 593**], MD Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2133-2-11**] 10:00  You have an appointment with Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 6164**], your primary care physician: [**Name Initial (NameIs) 2974**] [**2133-2-13**] at 11:30am.
